| Stage | PDEX | % of rev | OPXS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $20M | 100.00% | $10M | 100.00% | PDEX ×2.10 |
| Gross profit | $7M | 34.75% | $3M | 34.18% | PDEX +0.6pp |
| Operating income | $4M | 17.29% | $1M | 14.30% | PDEX +3.0pp |
| Pre-tax income | $4M | 17.27% | $1M | 14.59% | PDEX +2.7pp |
| Net income | $3M | 14.00% | $1M | 13.16% | PDEX +0.8pp |
| Stage | PDEX | OPXS | Gap · A − B |
|---|---|---|---|
| Revenue | $20M100.00% | $10M100.00% | PDEX ×2.10 |
| Gross profit | 34.75%$7M | 34.18%$3M | PDEX +0.6pp |
| Operating income | 17.29%$4M | 14.30%$1M | PDEX +3.0pp |
| Pre-tax income | 17.27%$4M | 14.59%$1M | PDEX +2.7pp |
| Net income |
| 14.00%$3M |
| 13.16%$1M |
| PDEX +0.8pp |
No disclosed counterparties: OPXS.
None